Login
$AXR
$20.99 +$0.40 (1.94%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Jul 31, 2026
Q4 FY2026
As of Apr 30, 2026
Q3 FY2026
As of Jan 31, 2026
Q2 FY2026
As of Oct 31, 2025
Q1 FY2026
As of Jul 31, 2025
Q4 FY2025
As of Apr 30, 2025
Q3 FY2025
As of Jan 31, 2025
Q2 FY2025
As of Oct 31, 2024
Q1 FY2025
As of Jul 31, 2024
Q4 FY2024
As of Apr 30, 2024
Q3 FY2024
As of Jan 31, 2024
Q2 FY2024
As of Oct 31, 2023
Q1 FY2024
As of Jul 31, 2023
Q4 FY2023
As of Apr 30, 2023
Q3 FY2023
As of Jan 31, 2023
Q2 FY2023
As of Oct 31, 2022
Q1 FY2023
As of Jul 31, 2022
Q4 FY2022
As of Apr 30, 2022
Q3 FY2022
As of Jan 31, 2022
Q2 FY2022
As of Oct 31, 2021
ASSETS
Cash and cash equivalents
Short-term investments
Restricted cash
Real estate inventory
Investment assets, net
Other assets
Income taxes receivable, net
Income taxes (payable) receivable, net
Deferred income taxes, net
Prepaid pension costs
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS' EQUITY
LIABILITIES:
Accounts payable and accrued expenses
Notes payable
Income taxes payable, net
TOTAL LIABILITIES
SHAREHOLDERS' EQUITY:
Common stock, $.10 par value; shares authorized - 20,000,000; shares issued - 5,324,849 at July 31, 2026 and 5,305,199 at April 30, 2026
Capital contributed in excess of par value
Retained earnings
Accumulated other comprehensive income, net
TOTAL SHAREHOLDERS' EQUITY
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support